Clinical Trials Logo

Radiofrequency Ablation clinical trials

View clinical trials related to Radiofrequency Ablation.

Filter by:

NCT ID: NCT04331184 Recruiting - Clinical trials for Carcinoma, Hepatocellular

RFA Using Combined Bipolar and Monopolar Energy Deliver With Twin Cooled-Wet Electrodes

Start date: January 28, 2020
Phase: N/A
Study type: Interventional

In this study, a dual / Twin Cooled-wet electrode was used to perform RFA therapy on residual tumors after transarterial chemo-embolization and to find out the therapeutic results. The primary endpoint is the 12-month local recurrence rate, and the secondary endpoint is the survival rate, disease-free survival rate, actual procedure time, complications associated with the procedure, and the technical success rate for securing a safety margin of 3 mm or more around the tumor.

NCT ID: NCT04150744 Recruiting - Immunosuppression Clinical Trials

RFA Plus Carrizumab vs Carrizumab Alone for HCC

Start date: August 1, 2020
Phase: Phase 2
Study type: Interventional

The study aims to find whether patients with advanced HCC can get more benefits from RFA +PD-1 immunosuppressant (carrizumab) compared with carrizumab alone, considering with the result of PFS.

NCT ID: NCT03574831 Recruiting - GERD Clinical Trials

the Efficency and Safety of Stretta in GERD

Start date: January 2, 2016
Phase:
Study type: Observational

This study evaluated the efficency and safety of the endoscopic radiofrequency procedure(Stretta) in adult gastroesophageal patients.

NCT ID: NCT03067493 Recruiting - Immunotherapy Clinical Trials

RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial

RAMEC
Start date: July 25, 2017
Phase: Phase 2
Study type: Interventional

RAMEC is a phase II, multi-center, randomized trial with a safety test. There will be a safety test to establish the safety and tolerability of Neo-MASCT treatment and assess the immune response to the treatment.The randomized trial will assess DFS and immune response.

NCT ID: NCT02793479 Recruiting - Clinical trials for Gastroesophageal Reflux Disease

Radiofrequency Ablation in Patients With Barrett's Esophagus

RABE
Start date: March 1, 2017
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to establish a nationwide registry to collect data regarding the treatment of Barrett's Esophagus (BE) with radiofrequency ablation. The objective of this registry is to increase the number of data and therefore obtain a raise of quality assurance and improve outcome and patient security. Furthermore to provide participating physicians information and experience for treatment details in the therapy of BE.

NCT ID: NCT01470495 Recruiting - HCC Clinical Trials

Combined Treatment of RFA and Sorafenib on Recurrent HCC

REPEAT
Start date: January 2015
Phase: N/A
Study type: Interventional

RFA is a routaine treatment of recurrent HCC. Recently Sorafenib was reported to be a promising drug to treat late stage HCC. But few studies were related with its effectiveness on recurrent HCC. So the investigators hypothesized that combined RFA and Sorafenib might reduce the frequency of recurrence and improve the overall survival and disease free survial.

NCT ID: NCT00750711 Recruiting - Clinical trials for Radiofrequency Ablation

Typical Flutter Ablation:A Comparison of 4 mm Versus 2 mm Irrigated cathéters

Start date: March 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the efficacy of 4 mm irrigated catheters with 2 mm irrigated catheters for ablation of typical flutter.It's a prospective randomised multicenter study.